2 days Denali Therapeutics’ ALS study fails to meet primary endpoint; shares fall 19% postmarket Investing.com X
2 days US regulator sues Berkshire-owned lender for making risky home loans, missing red flags Investing.com X
2 days GOP hardliners may be the next best hope for banning Congress from trading stocks Business Insider X
2 days Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal Investor's Business Daily X
2 days BTG Pactual to buy Julius Baer’s Brazil unit in $164 million deal, local media reports Investing.com X